Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Rheumatic Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Comment on “Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.Eur J Heart Fail. 2016; 18: 242-252
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.J Am Coll Cardiol. 2022; 79https://doi.org/10.1016/j.jacc.2021.12.012
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J. 2021; 42: 3599-3726
- Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.J Am Coll Cardiol. 2017; 69: 1275-1285
- Development of heart failure in patients with rheumatoid arthritis: A Danish population-based study.Eur J Clin Invest. 2018; 48: 1-8
- How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?.Arthritis Rheum. 2005; 52: 3039-3044
- The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years.Arthritis Rheum. 2005; 52: 412-420
- Heart Failure and Ischemic Heart Disease in Patients With Rheumatoid Arthritis.J Am Coll Cardiol. 2017; 70: 3069-3071
- Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study.Eur J Intern Med. 2021; 85: 41-49
- Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.Circulation. 2003; 107: 1303-1307
- Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.Arthritis Care Res. 2009; 61: 1571-1579
- Incidence of congestive heart failure in rheumatoid arthritis: a review of literature and meta-regression analysis.ESC Hear Fail. 2020; 7: 3745-3753
- The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review.Expert Opin Biol Ther. 2018; 18: 585-594
- Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: A consortium of rheumatology researchers of North America registry study.Arthritis Rheumatol. 2015; 67: 1995-2003
- Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.N Engl J Med. 2016; 375: 2519-2529
- Cardiac involvement in systemic lupus erythematosus.Mayo Clin Proc. 1999; 74: 275-284
- Incidence and risk of heart failure in systemic lupus erythematosus.Heart. 2017; 103: 227-233
- Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients.Semin Arthritis Rheum. 2019; 49: 389-395
- Heart failure in systemic lupus erythematosus.Trends Cardiovasc Med. 2018; 28: 187-197
- Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.J Am Coll Cardiol. 2021; 77: 1717-1727
- Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study.Am J Epidemiol. 1997; 145: 408-415
- Outcome in Systemic Lupus Erythematosus - A prospective Study of Patients from a Defined Population.Medicne. 1989; 68: 141-150
- Association of Congestive Heart Failure and Death with Ankylosing Spondylitis : A Nationwide Longitudinal Cohort Study in Korea.J Korean Neurosurg Soc. 2019; 62: 217-224
- Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.J Rheumatol. 2006; 33: 2167-2172
- Inflammatory Arthritis and Heart Disease.Curr Pharm Des. 2018; 24: 262-280
- Diastolic left ventricular dysfunction in ankylosing spondylitis--a systematic review and meta-analysis.Semin Arthritis Rheum. 2014; 44: 14-19
- Psoriasis is associated with clinically significant cardiovascular risk: A Danish nationwide cohort study.J Intern Med. 2011; 270: 147-157
- Incidence of and Risk Factors for Heart Failure in Patients With Psoriatic Disease: A Cohort Study.Arthritis Care Res (Hoboken). 2021; 74: 1244-1253
- Psoriasis and risk of heart failure: a nationwide cohort study.Eur J Heart Fail. 2014; 16: 743-748
- Associations of psoriatic arthritis and cardiovascular conditions in a large population.Perm J. 2008; 12: 4-8
- Cardiovascular morbidity in psoriatic arthritis.Ann Rheum Dis. 2009; 68: 1131-1135
- Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study.Clin Rheumatol. 2019; 38: 2069-2075
- Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies.Arthritis Care Res. 2017; 69: 67-74
- Association between gout and all-cause as well as cardiovascular mortality: A systematic review.Curr Rheumatol Rep. 2012; 14: 195-203
- Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study.Arthritis Res Ther. 2020; 22: 86
- Uric acid and risk of heart failure: A systematic review and meta-analysis.Eur J Heart Fail. 2014; 16: 15-24
- Gout and the risk for incident heart failure and systolic dysfunction.BMJ Open. 2012; 2: 1-8
- Asymptomatic hyperuricemia and incident congestive heart failure in elderly patients without comorbidities.Nutr Metab Cardiovasc Dis. 2020; 30: 666-673
- Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritis.Arthritis Rheum. 2011; 63: 1221-1230
- Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: Evidence for substantial undertreatment of lipid-associated cardiovascular risk?.Ann Rheum Dis. 2010; 69: 683-688
- Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.Rheumatol (United Kingdom). 2017; 56: 777-786
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.Arthritis Rheum. 2001; 44: 2331-2337
- Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis.Rheumatol (United Kingdom). 2016; 55: 1210-1216
- Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: Protocol for a multicentre randomised controlled trial.BMJ Open. 2016; 6https://doi.org/10.1136/bmjopen-2015-009134
- A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.J Am Coll Cardiol. 2013; 62: 263-271
- Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.Circ Hear Fail. 2011; 4: 44-52
- Inflammation – Cause or Consequence of Heart Failure or Both?.Curr Heart Fail Rep. 2017; 14: 251-265
- Transient Regenerative Potential of the Neonatal Mouse Heart.Science. 2011; 331 (.Transient): 1078-1080
- Immunomodulation for optimal cardiac regeneration: insights from comparative analyses.Npj Regen Med. 2021; 6: 1-11
- Activated T-Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure.Circ Hear Fail. 2017; 10 (Activated): e003688
- Adult T-cells impair neonatal cardiac regeneration.Eur Heart J. 2022; https://doi.org/10.1093/eurheartj/ehac153
- Heart regeneration: 20 years of progress and renewed optimism.Dev Cell. 2022; 57: 424-439
- Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD).J Am Coll Cardiol. 1996; 27: 1201-1206
- Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST).Circulation. 2001; 103: 2055-2059
- Inflammation in Atherosclerosis. From Pathophysiology to Practice.J Am Coll Cardiol. 2009; 54: 2129-2138
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis.Am J Med. 2008; 121https://doi.org/10.1016/j.amjmed.2008.06.014
- The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.Pharmacol Rev. 2000; 52: 595-638
- Psoriasis and risk of atrial fibrillation and ischaemic stroke: A Danish Nationwide Cohort Study.Eur Heart J. 2012; 33: 2054-2064
- Assessing QT interval in patients with autoimmune chronic inflammatory diseases: Perils and pitfalls.Lupus Sci Med. 2016; 3: 1-5
- Infliximab reduces cardiac output in rheumatoid arthritis patients without heart failure.Rev Assoc Med Bras. 2012; 58: 698-702
- Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).Circulation. 2004; 109: 1594-1602
- Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: Comparison with control subjects from the multi-ethnic study of atherosclerosis.Semin Arthritis Rheum. 2012; 41: 535-544
- Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis.Int J Clin Pract. 2014; 68: 520-528
- Evaluation of adalimumab effects in managing severe cases of COVID-19 : A randomized controlled trial.Int Immunopharmacol. 2021; 99: 107961
- Heart Failure, the Inflammasome, and Interleukin-1β: Prognostic and Therapeutic?.J Am Coll Cardiol. 2019; 73: 1026-1028
- Antiinflammatory therapy with canakinumab for atherosclerotic disease.N Engl J Med. 2017; 377: 1119-1131
- Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post-Hoc Pooled Analysis of Two Clinical Trials.J Cardiovasc Pharmacol. 2018; 72 (Effect): 68-70
- Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: Assessed using 3.0 tesla cardiac magnetic resonance imaging.J Rheumatol. 2014; 41: 1916-1921
- Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.Scand J Rheumatol. 2018; 47: 364-370
- Utility and safety of tocilizumab in Takayasu arteritis with severe heart failure and muscle wasting.ESC Hear Fail. 2019; 6: 894-897
- Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.Circulation. 2021; 143: 1841-1851
- Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.Lancet (London, England). 2008; 371: 228-236
- Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial.J Am Coll Cardiol. 2004; 44: 1181-1186
- Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle.Hypertens (Dallas, Tex 1979). 1995; 25: 343-349
- Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.JAMA. 1995; 273: 1450-1456
- Angiotensin-neprilysin inhibition versus enalapril in heart failure.N Engl J Med. 2014; 371: 993-1004
- CORT-AHF Study: Effect on Outcomes of Systemic Corticosteroid Therapy During Early Management Acute Heart Failure.JACC Heart Fail. 2019; 7: 834-845
- TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches.Molecules. 2020; 25https://doi.org/10.3390/molecules25030627
- Pentoxifylline in heart failure: A meta-analysis of clinical trials.Cardiovasc Ther. 2014; 32: 159-162
- Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin.Autoimmun Rev. 2004; 3: 221-227
- The Effects of METhotrexate Therapy on the Physical Capacity of Patients With ISchemic Heart Failure: A Randomized Double-Blind, Placebo-Controlled Trial (METIS Trial).J Card Fail. 2009; 15: 828-834
- Interleukin-1 blockade in recently decompensated systolic heart failure: Results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).Circ Hear Fail. 2017; 10: 1-11
- Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).Am J Cardiol. 2014; 113: 321-327
- Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.Am J Cardiol. 2018; 122: 1366-1370
- Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH.Circulation. 2003; 107: 3133-3140
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.Circulation. 2015; 131: 1763-1771
- Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.J Am Coll Cardiol. 2008; 51: 2301-2309
- Targeting NOS as a therapeutic approach for heart failure.Pharmacol Ther. 2014; 142: 306-315
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.Lancet (London, England). 2008; 372: 1231-1239
- Rosuvastatin in older patients with systolic heart failure.N Engl J Med. 2007; 357: 2248-2261
- Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study.JACC Heart Fail. 2014; 2: 131-137
- Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure.J Cardiovasc Pharmacol. 2020; 77: 49-60
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
